Bumps in the road: HIEs face economic, cultural obstacles

Health information exchanges (HIEs) not only need to move data, they need to do so securely, quickly and cost efficiently. The many competing interests inherent in the American healthcare system have meant certain obstacles must be scaled before HIE implementation can become ubiquitous. In June 28 column in the Wall Street Journal, David Blumenthal, MD, president of the Commonwealth Fund, discusses how the industry can best meet its patients' needs.

"The digitization of our health-care system is well under way, but several obstacles frustrate efforts to take full advantage of the health information revolution," writes Blumenthal. "Perhaps the most important is our difficulty moving patients’ data, so that records can follow patients as they go from one site of care to another."

For the full column, click on the link below:

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.